Abstract:Aim: Transplanted cells via coronary artery can migrate into the corresponding myocardium and avoid myocardial injury due to myocardial injection. It is a common used transplanted approach presently in clinical tests. However, a few scholars believed that transplantation via coronary artery could induce complications of myocardial infarction. This study aimed to investigate the feasibility and safety of injecting BMSCs into the coronary artery of myocardial infarction pigs. Methods: Experiments were performed at the Fuwai Cardiovascular Disease Hospital of Peking Union Medical College from June 2005 to March 2006. Female Chinese minipig aged 6 months were provided by Experimental Animal Center of China Agricultural University. The protocol was in accordance with animal ethical standards. BMSCs were harvested from bone marrow mononuclear cells of pigs by density gradient centrifugation, and then labeled with superparamagnetic iron oxide (SPIO) granules and fluorescent cell membrane marker CM-DiI. Pig model of myocardial infarction was made by ligating 1/3 anterior descending coronary artery for 90 minutes. BMSCs were injected into the coronary artery of myocardial infarction models. Electrocardiogram were recorded and plasma concentration of troponin I were measured before and after the transplantation. Cardiac magnetic resonance imaging (MRI) was used to trace the transplanted cells and evaluate the morphology and function of the heart before and after transplantation. Pathological examination was performed to analyze distribution of transplanted cells, redistribution of non-targeted organs and changes in tissue morphous. Results: No significant changes in ST-T or an increase in troponin I concentration were found by electrocardiogram immediately and 24 hours after transplantation. Left ventricular end diastolic volume (LVEDV) and left ventricular end systolic volume (LVESV) were not increased, and left ventricular ejection fraction (LVEF) was not decreased immediately and 24 hours after transplantation. Cardiac function was not improved, left ventricular volume (LVV) was significantly shortened, and LVEF was significantly increased 2 weeks after transplantation. No significant increase in troponin I concentration or significant changes in electrocardiogram were detected before, 24 hours and 48 hours after transplantation. Pathological examination demonstrated that transplanted cells were evenly distributed in myocardial tissues, and survived in the infarcted region two weeks later. The transplanted cells had redistribution to the non-targeted organs, but the structure of these organs remained normal. Conclusion: BMSCs can migrate into the corresponding tissues by coronary artery transplantation and cannot induce functional injury of infarcted myocardium, resulting in significant improvement of myocardial function and morphous of non-targeted organs remains normal. It is safe and feasible to treat pig with acute myocardial infarction by BMSCs transplantation via the coronary artery.

Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells Transfected by Angiogenin Gene in a Porcine Chromic Ischemic Heart Model

Transplantation of Autologous Angiogenin-Overexpressing Marrow Stromal Cells in Treatment of a Porcine Chronic Ischemia Model

Transplantation of VEGF Gene Transfected Autologous Marrow Stromal Cells in a Porcine Chronic Ischemic Heart Model

Therapeutic Angiogenesis of Bone Marrow Mononuclear Cells (mncs) and Peripheral Blood Mncs: Transplantation for Ischemic Hindlimb

[Therapeutic Neovascularization with Autologous Bone Marrow CD34+ Cells Transplantation in Hindlimb Ischemia].

Angiogenic Potential of Canine Bone Marrow Derived Mesenchymal Stem Cells in Ischemic Limb

Bone Marrow Mononuclear Cells Transplantation into the Heart Could Promote Angiogenesis and Improve Heart Function

Transplantation of Hypoxia-Preconditioned Mesenchymal Stem Cells Improves Infarcted Heart Function Via Enhanced Survival of Implanted Cells and Angiogenesis

Effects of Mesenchymal Stem Cells Transplantation on Post-Infarction Ventricular Remodeling in Rats

Mesenchymal Stem Cells Genetically Modified with the Angiopoietin-1 Gene Enhanced Arteriogenesis in a Porcine Model of Chronic Myocardial Ischaemia.

Studies on Transplantation of Bone Marrow Stromal Cells Transferred by Angiogenin Gene in Ischemic Myocardium

Neovascularization and Cardiomyocytes Regeneration in Acute Myocardial Infarction after Bone Marrow Stromal Cell Transplantation: Comparison of Infarct-Relative and Noninfarct-Relative Arterial Approaches in Swine.

Safety of intra-coronary artery injection of in vitro cultured bone marrow mesenchymal stem cells

Comparative Study of Effects of Bone Marrow Cell Vs. Ad5-HGF Administration Via Non-Infarct-related Artery Injection in Myocardial Infarction in Swine

Treatment of acute hog myocardial infarction by autologous bone marrow mesenchymal stem cells

Allograftic Bone Marrow-Derived Mesenchymal Stem Cells Transplanted into Heart Infarcted Model of Rabbit to Renovate Infarcted Heart

Optimal Temporal Delivery of Bone Marrow Mesenchymal Stem Cells in Rats with Myocardial Infarction.

Treatment of myocardial infarction by autologous mononuclear bone marrow cell transplantation in a swine model: analysis using imaging techniques

[Transplantation of Bone Marrow Cells Upregulated Vascular Endothelial Growth Factor and Its Receptor and Improved Ischemic Myocardial Function].

Transplantation of exogenous bone marrow mesenchymal stem cells by endocardium injection for treatment of acute myocardial infarction

Primary Study of Self-Transplantation of Bone Marrow Mesenchymal Stem Cell for Pigs with Acute Myocardial Infarction.